# Meclizine as a Potential Smoking Cessation Treatment

> **NCT01443858** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 146 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Meclizine
- **DRUG:** Nicotine Patch
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01443858
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-12
- **Final completion:** 2013-07
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2014-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01443858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01443858, "Meclizine as a Potential Smoking Cessation Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01443858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*